| APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa RJ Cho, LB Alexandrov, NY Den Breems, VS Atanasova, M Farshchian, ... Science Translational Medicine 10 (455), eaas9668, 2018 | 106 | 2018 |
| Serum lipid level in Iranian patients with psoriasis M Farshchian, A Zamanian, M Farshchian, AR Monsef, H Mahjub Journal of the European Academy of Dermatology and Venereology 21 (6), 802-805, 2007 | 94 | 2007 |
| Serpin peptidase inhibitor clade A member 1 (SerpinA1) is a novel biomarker for progression of cutaneous squamous cell carcinoma M Farshchian, A Kivisaari, R Ala-Aho, P Riihilä, M Kallajoki, R Grénman, ... The American journal of pathology 179 (3), 1110-1119, 2011 | 89 | 2011 |
| Complement factor I promotes progression of cutaneous squamous cell carcinoma P Riihilä, L Nissinen, M Farshchian, A Kivisaari, R Ala-Aho, M Kallajoki, ... Journal of Investigative Dermatology 135 (2), 579-588, 2015 | 82 | 2015 |
| New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma L Nissinen, M Farshchian, P Riihilä, VM Kähäri Cell and tissue research 365, 691-702, 2016 | 81 | 2016 |
| Complement component C3 and complement factor B promote growth of cutaneous squamous cell carcinoma P Riihilä, L Nissinen, M Farshchian, M Kallajoki, A Kivisaari, S Meri, ... The American Journal of Pathology 187 (5), 1186-1197, 2017 | 74 | 2017 |
| Long noncoding RNA PICSAR promotes growth of cutaneous squamous cell carcinoma by regulating ERK1/2 activity M Piipponen, L Nissinen, M Farshchian, P Riihilä, A Kivisaari, M Kallajoki, ... Journal of Investigative Dermatology 136 (8), 1701-1710, 2016 | 74 | 2016 |
| Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma M Farshchian, L Nissinen, E Siljamäki, P Riihilä, M Piipponen, A Kivisaari, ... Oncotarget 8 (28), 45825, 2017 | 70 | 2017 |
| EphB2 promotes progression of cutaneous squamous cell carcinoma M Farshchian, L Nissinen, E Siljamäki, P Riihilä, M Toriseva, A Kivisaari, ... Journal of Investigative Dermatology 135 (7), 1882-1892, 2015 | 62 | 2015 |
| Subantimicrobial-dose doxycycline in the treatment of moderate facial acne. P Toossi, M Farshchian, F Malekzad, N Mohtasham, A Kimyai-Asadi Journal of drugs in dermatology: JDD 7 (12), 1149-1152, 2008 | 61 | 2008 |
| Treatment of common warts with an intralesional mixture of 5-fluorouracil, lidocaine, and epinephrine: a prospective placebo-controlled, double-blind randomized trial A Yazdanfar, M Farshchian, M Fereydoonnejad, M Farshchian Dermatologic surgery 34 (5), 656-659, 2008 | 55 | 2008 |
| Tumour‐cell‐derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma P Riihilä, K Viiklepp, L Nissinen, M Farshchian, M Kallajoki, A Kivisaari, ... British Journal of Dermatology 182 (3), 658-670, 2020 | 44 | 2020 |
| CUTIS Do Not Copy M Farshchian, M Farshchian, M Fereydoonnejad, A Yazdanfar, ... Cutis 86, 31-35, 2010 | 40 | 2010 |
| p53-regulated long noncoding RNA PRECSIT promotes progression of cutaneous squamous cell carcinoma via STAT3 signaling M Piipponen, L Nissinen, P Riihilä, M Farshchian, M Kallajoki, J Peltonen, ... The American Journal of Pathology 190 (2), 503-517, 2020 | 38 | 2020 |
| Identification of rigosertib for the treatment of recessive dystrophic epidermolysis bullosa–associated squamous cell carcinoma VS Atanasova, C Pourreyron, M Farshchian, M Lawler, CA Brown IV, ... Clinical Cancer Research 25 (11), 3384-3391, 2019 | 31 | 2019 |
| Thyroid autoimmunity in Iranian patients with pemphigus vulgaris. A Ansar, M Farshchian, S Farahnaki Journal of the European Academy of Dermatology and Venereology: JEADV 23 (6 …, 2009 | 28 | 2009 |
| Drug-induced skin reactions: a 2-year study M Farshchian, A Ansar, A Zamanian, G Rahmatpour-Rokni, ... Clinical, cosmetic and investigational dermatology, 53-56, 2015 | 27 | 2015 |
| Cutaneous manifestations in 404 Iranian patients with inflammatory bowel disease: a retrospective study H Moravvej, GM Razavi, M Farshchian, R Malekzadeh Indian Journal of Dermatology, Venereology and Leprology 74, 607, 2008 | 27 | 2008 |
| Rosacea M Farshchian, S Daveluy | 26 | 2020 |
| Dasatinib promotes apoptosis of cutaneous squamous carcinoma cells by regulating activation of ERK1/2. M Farshchian, L Nissinen, R Grénman, VM Kähäri Experimental Dermatology 26 (1), 2017 | 26 | 2017 |
